Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 29INDUSTRY 8OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Metastatic Gastroesophageal Junction Adenocarcinoma 1MSS Metastatic Colorectal Cancer 1Gastric/Gastroesophageal Junction Adenocarcinoma 1

Interventions

pembrolizumab 9Drug Therapy 9Bevacizumab 9Radiotherapy 8Carboplatin 8Oxaliplatin 7Cyclophosphamide 7Surgical Procedures, Operative 6Cisplatin 6Capecitabine 6tislelizumab 5Paclitaxel 5Fluorouracil 5Docetaxel 5Control Groups 5Nivolumab 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3fludarabine 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × HMPL-013 × Clear all
NCT06329973 2025-07-17

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Henan Cancer Hospital

Phase 1/2 Recruiting
70 enrolled
Gastrointestinal

Metastatic Gastroesophageal Junction Adenocarcinoma

NCT06774222 2025-01-14

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Henan Cancer Hospital

Phase 2 Recruiting
69 enrolled
Gastrointestinal

Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06613113 2024-09-25

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

Ningbo Medical Center Lihuili Hospital

Phase NA Recruiting
30 enrolled
Gastrointestinal

MSS Metastatic Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡